HOME > TOP STORIES
TOP STORIES
-
BUSINESS Astellas to End License Agreement with US Venture Company for AD Treatments
October 20, 2014
-
BUSINESS Bayer AG Aims to Achieve Japan Sales of 300 Billion Yen by 2017
October 17, 2014
-
REGULATORY NIBIO to Begin Drug Seed Optimization Project from FY2015
October 16, 2014
-
REGULATORY 4 Die after Taking SGLT-2 Inhibitors, Causality under Scrutiny
October 15, 2014
-
BUSINESS Parexel CEO Hails Rise of Partnership-Based Outsourcing in Japan
October 14, 2014
-
ACADEMIA St. Marianna Hospital Elbows Drug Makers to Reveal Detailing Costs Embedded in Drug Prices
October 10, 2014
-
BUSINESS GSK to Market Authorized Generics through Aspen Japan Unit
October 10, 2014
-
REGULATORY MOF Panel to Pitch Reference Pricing for Long-Listed Drugs, Price Cut in FY2015
October 9, 2014
-
BUSINESS Shire Japan Takes Aim at $500 Million Sales in 10 Years
October 8, 2014
-
BUSINESS Chugai, Roche Chiefs Were in Talks on Recent Deal Change from 2 Years Ago
October 7, 2014
-
BUSINESS JCR Pharmaceuticals Hopes to Make Japan’s First Cell Product into New Profit Pillar
October 6, 2014
-
ORGANIZATION JPMA Plans Disclosure of Recipients, Amount of Payments for R&D Outlays
October 3, 2014
-
BUSINESS MTPC Charges Ahead with Research Lab Overhaul to Buttress Drug Discovery
October 2, 2014
-
BUSINESS Novartis Pharma Notifies PMDA of Additional 1,299 Unreported Serious ADRs
October 2, 2014
-
BUSINESS Kissei to Spice Up Current Portfolio in Next 3 Years, Launch New Drugs Later
October 1, 2014
-
BUSINESS e-Detailing Powerhouse M3 to Establish New Firm Dedicated to CSO Biz
September 30, 2014
-
BUSINESS Avigan Administered to Ebola-Infected French Woman: Fujifilm
September 29, 2014
-
ORGANIZATION JPMA Weighs Disclosure of Ad Payments to Commercial Medical Publishers
September 26, 2014
-
BUSINESS Takeda to Invest 2.5 Billion Yen in US Firm for New Drug Development
September 26, 2014
-
BUSINESS AZ Managed to Speed Up Pilot R&D Projects under New Structure: President
September 25, 2014
ページ
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
